InsiderTrades

Form 4 for SPRY ARS Pharmaceuticals, Inc.

Accepted 2024-01-04 00:00:00 ET · period of report 2023-05-17 · accession 0001209191-24-000815 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2024-01-04 2023-05-17 SPRY Tanimoto Sarina Chief Medical Off, 10% G - Gift $0.00 +1.05M 1.05M New $0
D 2024-01-04 2023-05-17 SPRY Tanimoto Sarina Chief Medical Off, 10% G - Gift $0.00 -1.05M 3.28M -24% $0
DI 2024-01-04 2024-01-02 SPRY Tanimoto Sarina Chief Medical Off, 10% A - Grant $0.00 +880.0K 880.0K New $0
D 2024-01-04 2024-01-02 SPRY Tanimoto Sarina Chief Medical Off, 10% A - Grant $0.00 +300.0K 300.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-17 G D 1,050,000 $0.00 4,126,822 I By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 — — (F2) The Form 4 filed November 10, 2022 inadvertently omitted 849,968 shares indirectly owned by the Reporting Person. The omitted shares are directly owned by the Reporting Person's spouse and were properly reported on his Form 4 filed November 10, 2022. The amount listed in Column 5 has been adjusted to reflect the correct holdings after giving effect to the May 17, 2023 gift transaction. (F1) These shares are held in a trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of the trust.
2 Common Common Stock 2023-05-17 G A 1,050,000 $0.00 2,100,000 I — —
3 Common Common Stock 2023-05-17 G A 1,050,000 $0.00 1,050,000 I By spouse — —
4 Common Common Stock 2023-05-17 G D 1,050,000 $0.00 3,276,854 D By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 — — (F1) These shares are held in a trust for the benefit of the Reporting Person and her spouse. The Reporting Person and her spouse are trustees of the trust.
5 Derivative Stock option (right to buy) 2024-01-02 A A 880,000 $0.00 880,000 I $5.58 · — to 2034-01-01 880,000 Common Stock (F5) 25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.
6 Derivative Stock option (right to buy) 2024-01-02 A A 300,000 $0.00 300,000 D By spouse $5.58 · — to 2034-01-01 300,000 Common Stock (F5) 25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.